Skip to content

Resistance Training as an Aid to Smoking Cessation Treatment

Resistance Training as an Aid to Smoking Cessation Treatment

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01951456
Enrollment
180
Registered
2013-09-26
Start date
2013-11-30
Completion date
2019-03-31
Last updated
2020-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cigarette Smoking

Keywords

Smoking cessation, resistance training

Brief summary

The purpose of this study is to determine whether resistance training can aid smoking cessation.

Interventions

BEHAVIORALResistance training

Sponsors

Brown University
CollaboratorOTHER
Teachers College, Columbia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Age 18 or older, smoke five or more cigarettes a day for at least the past 12 months

Exclusion criteria

Participating in any type of exercise for \>60 minutes/week over the past 3 months, current smokeless tobacco use, participation in an ongoing effort to quit smoking, current or planned pregnancy, any serious medical condition that would make exercise unsafe

Design outcomes

Primary

MeasureTime frameDescription
Smoking cessationChange from baseline to 3 monthsSalivary cotinine-verified 7-day Point Prevalence Abstinence (7-day PPA) from nicotine (cigarette smoking).

Secondary

MeasureTime frameDescription
Muscular strength3, 6, 12 months
Aerobic fitness3, 6, 12 monthsSix-minute walk test
Smoking cessationChange from baseline to 6 monthsSalivary cotinine-verified 7-day Point Prevalence Abstinence (7-day PPA) from nicotine (cigarette smoking).
Cortisol3, 6, 12 months
Mood3, 6, 12 months
Cigarette cravings3, 6, 12 months
Glycosylated hemoglobin3, 6, 12 months
Sleep3, 6, 12 months
Body composition3, 6, 12 months
Body weight3, 6, 12 months
Lung function3, 6, 12 months
Blood pressure3, 6, 12 months
Cholesterol profile3, 6, 12 months
Abstinence self-efficacy3, 6, 12 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026